First Trust Advisors
RCUS icon

First Trust Advisors’s Arcus Biosciences RCUS Stock Holding History

First Trust Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Buy
+13,098
New +$283K ﹤0.01% 2483
2025
Q1 		– Sell
-17,708
Closed -$264K – 2606
2024
Q4 		$264K Buy
17,708
+5,337
+43% +$87.2K ﹤0.01% 2410
2024
Q3 		$189K Buy
12,371
+1,796
+17% +$28.3K ﹤0.01% 2321
2024
Q2 		$161K Buy
+10,575
New +$171K ﹤0.01% 2273
2023
Q2 		– Sell
-15,845
Closed -$289K – 2431
2023
Q1 		$289K Sell
15,845
-83,839
-84% -$1.6M ﹤0.01% 2245
2022
Q4 		$2.06M Buy
99,684
+14,924
+18% +$411K ﹤0.01% 1689
2022
Q3 		$2.22M Buy
84,760
+14,110
+20% +$373K ﹤0.01% 1637
2022
Q2 		$1.79M Buy
70,650
+18,761
+36% +$459K ﹤0.01% 1770
2022
Q1 		$1.64M Sell
51,889
-106,838
-67% -$3.58M ﹤0.01% 1847
2021
Q4 		$6.42M Buy
158,727
+138,808
+697% +$5.38M 0.01% 1237
2021
Q3 		$695K Sell
19,919
-84,659
-81% -$2.63M ﹤0.01% 2169
2021
Q2 		$2.87M Sell
104,578
-36,519
-26% -$1.04M ﹤0.01% 1668
2021
Q1 		$3.96M Buy
141,097
+92,147
+188% +$3.21M ﹤0.01% 1376
2020
Q4 		$1.27M Buy
+48,950
New +$1.18M ﹤0.01% 1794

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

First Trust Advisors's RCUS Position: Q1 2026 in Review

First Trust Advisors opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 13,098 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #2483 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in RCUS as recently as Q4 2024.

First Trust Advisors first reported a position in RCUS in Q4 2020 and has held it in 14 quarters since. The position peaked at $6.42M in Q4 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • First Trust Advisors held 13,098 shares of Arcus Biosciences worth $283K as of Q1 2026.
  • Arcus Biosciences was a new First Trust Advisors position in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #2483 holding.
  • First Trust Advisors first reported a position in Arcus Biosciences in Q4 2020 and has held it in 14 quarters since.
  • First Trust Advisors's Arcus Biosciences position peaked at $6.42M in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.